Cargando…

Interleukin‐18 in patients with acute coronary syndromes

BACKGROUND: We aimed to assess associations between circulating IL‐18 concentrations and cardiovascular outcomes in patients with acute coronary syndromes (ACS). HYPOTHESIS AND METHODS: Plasma IL‐18 concentrations were measured at admission, discharge, 1 month, and 6 months in patients with ACS in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Åkerblom, Axel, James, Stefan K., Lakic, Tatevik G., Becker, Richard C., Cannon, Christopher P., Steg, Philippe G., Himmelmann, Anders, Katus, Hugo A., Storey, Robert F., Wallentin, Lars, Weaver, W. Douglas, Siegbahn, Agneta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2019
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906991/ https://www.ncbi.nlm.nih.gov/pubmed/31596518 http://dx.doi.org/10.1002/clc.23274

Ejemplares similares

Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
por: Åkerblom, Axel, et al.
Publicado: (2019)

Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial
por: Ueland, Thor, et al.
Publicado: (2018)

Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding
por: Lindholm, Daniel, et al.
Publicado: (2017)

Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial
por: Gregersen, Ida, et al.
Publicado: (2020)

Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial
por: Hjort, Marcus, et al.
Publicado: (2022)

Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study
por: Sumaya, Wael, et al.
Publicado: (2020)

Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy
por: Sumaya, Wael, et al.
Publicado: (2018)

Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y(12) Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial
por: Franchi, Francesco, et al.
Publicado: (2019)

Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
por: Held, Claes, et al.
Publicado: (2017)

Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial
por: Batra, Gorav, et al.
Publicado: (2022)

Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome
por: Johansson, Åsa, et al.
Publicado: (2015)

The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial
por: Husted, Steen, et al.
Publicado: (2014)

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study
por: Storey, Robert F., et al.
Publicado: (2014)

Prediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy
por: Hilvo, Mika, et al.
Publicado: (2020)

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial
por: Andell, Pontus, et al.
Publicado: (2015)

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial
por: Lindholm, Daniel, et al.
Publicado: (2014)

Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial
por: James, Stefan K, et al.
Publicado: (2011)

Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome
por: Mälarstig, A, et al.
Publicado: (2008)

Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials
por: Hijazi, Ziad, et al.
Publicado: (2020)

Time-based measures of treatment effect: reassessment of ticagrelor and clopidogrel from the PLATO trial
por: Bellavia, Andrea, et al.
Publicado: (2017)

GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men
por: Wallentin, Lars, et al.
Publicado: (2013)

Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis
por: Mahmoodi, Bakhtawar K., et al.
Publicado: (2021)

Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease
por: Varenhorst, Christoph, et al.
Publicado: (2009)

High levels of HB-EGF and interleukin-18 are associated with a high risk of in-stent restenosis
por: Jiang, Hua, et al.
Publicado: (2016)

Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials
por: Mahmoodi, Bakhtawar K., et al.
Publicado: (2021)

Screening for Biomarkers Associated with Left Ventricular Function During Follow-up After Acute Coronary Syndrome
por: Christersson, Christina, et al.
Publicado: (2022)

Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)
por: Siegbahn, Agneta, et al.
Publicado: (2023)

New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis
por: Oldgren, Jonas, et al.
Publicado: (2013)

Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
por: Wallentin, Lars, et al.
Publicado: (2021)

Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events
por: Attelind, Sofia, et al.
Publicado: (2022)

Decreased levels of interleukin 27 in the serum of vitiligo patients()()
por: Hosseini, Saeed Malek, et al.
Publicado: (2020)

Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial
por: Amarenco, Pierre, et al.
Publicado: (2020)

The expression of interleukin-25 increases in human coronary artery disease and is associated with the severity of coronary stenosis
por: Xu, Yao, et al.
Publicado: (2020)

IκBζ is a Key Regulator of Tumour Necrosis Factor-α and Interleukin-17A-mediated Induction of Interleukin-36η in Human Keratinocytes
por: OVESEN, Sofie Kaas, et al.
Publicado: (2021)

Association of Interleukin-1 Gene cluster polymorphisms with coronary slow flow phenomenon
por: Mutluer, Ferit Onur, et al.
Publicado: (2018)

Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy
por: Janzon, M, et al.
Publicado: (2015)

The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients
por: Christersson, Christina, et al.
Publicado: (2017)

Design and Analysis of Bar-seq Experiments
por: Robinson, David G., et al.
Publicado: (2013)

Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial
por: Wang, Yongjun, et al.
Publicado: (2021)

Temporal Changes in Coronary (18)F-Fluoride Plaque Uptake in Patients with Coronary Atherosclerosis
por: Daghem, Marwa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vfef415u9hoj00datd1kjvnvnv